• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项针对具有不同临床表型的多发性硬化症患者灰质损失的基于体素的形态学研究。

A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes.

作者信息

Ceccarelli Antonia, Rocca Maria A, Pagani Elisabetta, Colombo Bruno, Martinelli Vittorio, Comi Giancarlo, Filippi Massimo

机构信息

Neuroimaging Research Unit, Scientific Institute and University Ospedale San Raffaele, Milan, Italy.

出版信息

Neuroimage. 2008 Aug 1;42(1):315-22. doi: 10.1016/j.neuroimage.2008.04.173. Epub 2008 Apr 20.

DOI:10.1016/j.neuroimage.2008.04.173
PMID:18501636
Abstract

To assess regional grey matter (GM) changes in a large cohort of multiple sclerosis (MS) patients with different clinical phenotypes, using voxel-based morphometry (VBM) and their correlation with the extent of global and regional T2 lesion volumes (LV), we acquired conventional MRI scans from 71 MS patients with different clinical phenotypes (26 with relapsing-remitting [RR] MS, 27 with secondary progressive [SP] MS and 18 with primary progressive [PP] MS), 28 patients with a clinically isolated syndrome (CIS) suggestive of MS, and 21 controls. No GM loss was found in CIS patients. Compared to CIS patients, those with RRMS had a significant GM loss in the right pre and postcentral gyri. Compared to RRMS, SPMS patients had a significant GM loss in several regions of the fronto-parieto-temporo-occipital lobes, the cerebellum and superior and inferior colliculus, bilaterally, and deep GM structures. Compared to PPMS, SPMS patients had a significant GM loss in the postcentral gyrus, the cuneus, the middle occipital gyrus, the thalamus, the cerebellum, and the superior and inferior colliculus. In all MS groups, regional GM loss was strongly/moderately correlated with brain T2 LV. In SPMS and PPMS patients, a correlation was found between cortical regional GM loss and T2 LV of the corresponding or adjacent lobes. In MS patients, GM volume loss follows different patterns of regional distribution according to the clinical phenotype of the disease, is likely secondary to the presence and topography of focal WM inflammatory-demyelinating lesions, and is more evident in the progressive forms of the disease.

摘要

为了使用基于体素的形态学测量(VBM)方法评估一大群具有不同临床表型的多发性硬化症(MS)患者的区域灰质(GM)变化及其与整体和区域T2病变体积(LV)范围的相关性,我们对71例具有不同临床表型的MS患者(26例复发缓解型[RR]MS、27例继发进展型[SP]MS和18例原发进展型[PP]MS)、28例提示MS的临床孤立综合征(CIS)患者以及21名对照者进行了常规MRI扫描。在CIS患者中未发现GM丢失。与CIS患者相比,RRMS患者在右侧中央前回和中央后回有显著的GM丢失。与RRMS相比,SPMS患者在双侧额顶颞枕叶、小脑、上丘和下丘以及深部GM结构的多个区域有显著的GM丢失。与PPMS相比,SPMS患者在中央后回、楔叶、枕中回、丘脑、小脑以及上丘和下丘有显著的GM丢失。在所有MS组中,区域GM丢失与脑T2 LV强烈/中度相关。在SPMS和PPMS患者中,发现皮质区域GM丢失与相应或相邻叶的T2 LV之间存在相关性。在MS患者中,GM体积丢失根据疾病的临床表型遵循不同的区域分布模式,可能继发于局灶性白质炎性脱髓鞘病变的存在和位置,并且在疾病的进展形式中更为明显。

相似文献

1
A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes.一项针对具有不同临床表型的多发性硬化症患者灰质损失的基于体素的形态学研究。
Neuroimage. 2008 Aug 1;42(1):315-22. doi: 10.1016/j.neuroimage.2008.04.173. Epub 2008 Apr 20.
2
Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: a voxel-based analysis study.多发性硬化临床亚组中灰质萎缩和磁化传递率异常的区域模式:一项基于体素的分析研究。
Mult Scler. 2015 Apr;21(4):423-32. doi: 10.1177/1352458514546513. Epub 2014 Aug 21.
3
Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.视神经脊髓炎与多发性硬化症患者脑灰质萎缩的比较:基于体素的形态计量学研究。
Eur J Radiol. 2012 Feb;81(2):e110-4. doi: 10.1016/j.ejrad.2011.01.065. Epub 2011 Feb 11.
4
Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype.多发性硬化症的认知障碍与根据临床表型的不同灰质萎缩模式有关。
Hum Brain Mapp. 2011 Oct;32(10):1535-43. doi: 10.1002/hbm.21125. Epub 2010 Aug 25.
5
Deep gray matter volume loss drives disability worsening in multiple sclerosis.深部灰质体积损失导致多发性硬化症残疾恶化。
Ann Neurol. 2018 Feb;83(2):210-222. doi: 10.1002/ana.25145. Epub 2018 Feb 6.
6
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症中区域脑萎缩进展的体素水平评估
J Neurol Sci. 2009 Jul 15;282(1-2):55-60. doi: 10.1016/j.jns.2009.02.322. Epub 2009 Mar 16.
7
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis.脑灰质萎缩模式与多发性硬化临床表型和进展的相关性研究。
Neurology. 2021 Mar 16;96(11):e1561-e1573. doi: 10.1212/WNL.0000000000011494. Epub 2021 Jan 13.
8
Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.在复发缓解型多发性硬化症中,颈髓区域主要与幕下灰质和白质体积相关:一项使用半自动脊髓容积测量法和基于体素的形态测量学的研究
Mult Scler Relat Disord. 2015 May;4(3):264-72. doi: 10.1016/j.msard.2015.04.003. Epub 2015 Apr 15.
9
Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study.解析复发缓解型多发性硬化的异质性病理基础:一项基于体素的多参数 3T MRI 研究。
J Neurol. 2023 Aug;270(8):3839-3850. doi: 10.1007/s00415-023-11736-9. Epub 2023 Apr 24.
10
Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis. 复发缓解型多发性硬化症的区域性灰质和白质萎缩的研究。
Mult Scler. 2012 Jul;18(7):1027-37. doi: 10.1177/1352458512439239. Epub 2012 Mar 15.

引用本文的文献

1
Brain Atrophy and Cognitive Impairment in Primary and Secondary Progressive Multiple Sclerosis Cohort-Similar Progressive MS Phenotype.原发进展型和继发进展型多发性硬化队列中的脑萎缩与认知障碍——相似的进展型多发性硬化表型
Int J Mol Sci. 2025 Sep 2;26(17):8523. doi: 10.3390/ijms26178523.
2
The relationship between work difficulties and physical disability, cognitive and social cognitive impairment and subcortical gray matter atrophy in persons with multiple sclerosis.多发性硬化症患者工作困难与身体残疾、认知及社会认知障碍和皮质下灰质萎缩之间的关系。
Acta Neurol Belg. 2024 Dec;124(6):1891-1898. doi: 10.1007/s13760-024-02609-7. Epub 2024 Jul 24.
3
Automatic estimation of brain parenchymal fraction in patients with multple sclerosis: a comparison between synthetic MRI and an established automated brain segmentation software based on FSL.
基于 FSL 的合成 MRI 与成熟自动脑区分割软件对多发性硬化患者脑实质分数的自动评估比较
Neuroradiology. 2024 Feb;66(2):193-205. doi: 10.1007/s00234-023-03264-0. Epub 2023 Dec 18.
4
A systematic comparison of VBM pipelines and their application to age prediction.基于体素的形态学分析(VBM)方法的系统比较及其在年龄预测中的应用。
Neuroimage. 2023 Oct 1;279:120292. doi: 10.1016/j.neuroimage.2023.120292. Epub 2023 Aug 11.
5
Association of multiple sclerosis with chronic fatigue syndrome, restless legs syndrome, and various sleep disorders, along with the recent updates.多发性硬化症与慢性疲劳综合征、不宁腿综合征及各种睡眠障碍的关联,以及近期的更新情况。
Ann Med Surg (Lond). 2023 May 26;85(6):2821-2832. doi: 10.1097/MS9.0000000000000929. eCollection 2023 Jun.
6
Structural and functional brain damage in women with multiple sclerosis: A mini-review of neuroimaging sex-based studies.多发性硬化症女性的脑结构和功能损伤:基于神经影像学性别研究的小型综述
Front Neurol. 2022 Dec 22;13:1057446. doi: 10.3389/fneur.2022.1057446. eCollection 2022.
7
Machine learning in neuroimaging: from research to clinical practice.神经影像学中的机器学习:从研究到临床实践。
Radiologie (Heidelb). 2022 Dec;62(Suppl 1):1-10. doi: 10.1007/s00117-022-01051-1. Epub 2022 Aug 31.
8
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study.血清神经丝轻链作为多发性硬化症10年灰质萎缩和临床残疾的预测指标:一项纵向研究
J Neurol Neurosurg Psychiatry. 2022 Jun 1;93(8):849-57. doi: 10.1136/jnnp-2021-328568.
9
Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis Phenotypes.解析原发性进行性和复发缓解型多发性硬化表型的 MRI 基础结构特征。
J Magn Reson Imaging. 2022 Jan;55(1):154-163. doi: 10.1002/jmri.27806. Epub 2021 Jun 30.
10
Network Damage Predicts Clinical Worsening in Multiple Sclerosis: A 6.4-Year Study.网络损伤预测多发性硬化症的临床恶化:一项 6.4 年的研究。
Neurol Neuroimmunol Neuroinflamm. 2021 May 21;8(4). doi: 10.1212/NXI.0000000000001006. Print 2021 Jul.